Published online before print January 16, 2003, doi: 10.1161/01.ATV.0000056744.26901.BA
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2003 American Heart Association, Inc.
Vascular Biology |
Glucose-6-Phosphate Dehydrogenase Overexpression Decreases Endothelial Cell Oxidant Stress and Increases Bioavailable Nitric Oxide
From the Whitaker Cardiovascular Institute and Evans Department of Medicine (J.A.L., Y.-Y.Z., B.W.S., J.L.), Boston University School of Medicine and Joslin Diabetes Center (R.C.S.), Harvard Medical School, Boston, Mass.
Correspondence to Jane A. Leopold, MD, Whitaker Cardiovascular Institute, Boston University School of Medicine, 700 Albany St CABR W-507, Boston, MA 02118. E-mail Jane.Leopold{at}bmc.org
Objective— Glucose-6-phosphate dehydrogenase (G6PD), the principal source of NADPH, serves as an antioxidant enzyme to modulate the redox milieu and nitric oxide synthase activity. Deficient G6PD activity is associated with increased endothelial cell oxidant stress and diminished bioavailable nitric oxide (NO·). Therefore, we examined whether overexpression of G6PD would decrease reactive oxygen species accumulation and increase bioavailable NO· in endothelial cells.
Methods and Results— Adenoviral-mediated gene transfer of G6PD increased G6PD expression, activity, and NADPH levels in bovine aortic endothelial cells (BAECs). BAECs overexpressing G6PD demonstrated a significant reduction in reactive oxygen species accumulation when exposed to hydrogen peroxide, xanthine-xanthine oxidase, or tumor necrosis factor-
compared with BAECs with basal levels of G6PD. BAECs overexpressing G6PD maintained intracellular glutathione stores when exposed to oxidants because of increased activity of glutathione reductase, an effect that was not observed in endothelial cells with normal G6PD activity. Overexpression of G6PD was also associated with enhanced nitric oxide synthase activity, resulting in elevated levels of cGMP, nitrate, and nitrite, and this response was increased after stimulation with bradykinin.
Conclusions— Overexpression of G6PD in vascular endothelial cells decreases reactive oxygen species accumulation in response to exogenous and endogenous oxidant stress and improves levels of bioavailable NO·.
Key Words: glucose-6-phosphate dehydrogenase • oxidant stress • endothelium • nitric oxide • nitric oxide synthase
This article has been cited by other articles:
 |
|
 |
|
  E. Mata-Greenwood and D.-B. Chen Racial Differences in Nitric Oxide--Dependent Vasorelaxation Reproductive Sciences, January 1, 2008; 15(1): 9 - 25. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Liu, R. Wu, Q. Wan, G. Xie, and Y. Bi Glucose-6-Phosphate Dehydrogenase Plays a Pivotal Role in Nitric Oxide-Involved Defense Against Oxidative Stress Under Salt Stress in Red Kidney Bean Roots Plant Cell Physiol., March 1, 2007; 48(3): 511 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Galasso, S. Schiekofer, K. Sato, R. Shibata, D. E. Handy, N. Ouchi, J. A. Leopold, J. Loscalzo, and K. Walsh Impaired Angiogenesis in Glutathione Peroxidase-1-Deficient Mice Is Associated With Endothelial Progenitor Cell Dysfunction Circ. Res., February 3, 2006; 98(2): 254 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu, B. W. Osborne, and R. C. Stanton Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1040 - F1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Matsui, S. Xu, K. A. Maitland, A. Hayes, J. A. Leopold, D. E. Handy, J. Loscalzo, and R. A. Cohen Glucose-6 Phosphate Dehydrogenase Deficiency Decreases the Vascular Response to Angiotensin II Circulation, July 12, 2005; 112(2): 257 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Leopold and J. Loscalzo Oxidative Enzymopathies and Vascular Disease Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1332 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Benjamin, D. K. Arnett, and J. Loscalzo Discovering the Full Spectrum of Cardiovascular Disease: Minority Health Summit 2003: Report of the Basic Science Writing Group Circulation, March 15, 2005; 111(10): e120 - e123. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Alp, M. A. McAteer, J. Khoo, R. P. Choudhury, and K. M. Channon Increased Endothelial Tetrahydrobiopterin Synthesis by Targeted Transgenic GTP-Cyclohydrolase I Overexpression Reduces Endothelial Dysfunction and Atherosclerosis in ApoE-Knockout Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 445 - 450. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y.-J. Lee, I.-J. Kang, R. Bunger, and Y.-H. Kang Enhanced survival effect of pyruvate correlates MAPK and NF-{kappa}B activation in hydrogen peroxide-treated human endothelial cells J Appl Physiol, February 1, 2004; 96(2): 793 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Leopold, J. Walker, A. W. Scribner, B. Voetsch, Y.-Y. Zhang, A. J. Loscalzo, R. C. Stanton, and J. Loscalzo Glucose-6-phosphate Dehydrogenase Modulates Vascular Endothelial Growth Factor-mediated Angiogenesis J. Biol. Chem., August 22, 2003; 278(34): 32100 - 32106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jain, D. A. Brenner, L. Cui, C. C. Lim, B. Wang, D. R. Pimentel, S. Koh, D. B. Sawyer, J. A. Leopold, D. E. Handy, et al. Glucose-6-Phosphate Dehydrogenase Modulates Cytosolic Redox Status and Contractile Phenotype in Adult Cardiomyocytes Circ. Res., July 25, 2003; 93 (2): e9 - e16. [Abstract] [Full Text] [PDF]
|
|